Targeting the C3a–C3aR and C5a–C5aR1 pathways and their influence on adhesion molecule-mediated immune cell infiltration holds significant promise for mitigating inflammation and potentially halting or slowing the progression of organ damage in Fabry disease. This evidence concerns the gene C5 and Fabry disease.